|
|
Title | Creator | Date |
1 |
|
Visual Pathway Axonal Loss in Benign Multiple Sclerosis | Galetta, Kristin M; Graves, Jennifer; Talman, Lauren S; Lile, Deacon J; Frohman, Elliot M; Calabresi, Peter A; Galetta, Steven L; Balcer, Laura J | |
2 |
|
Retinal Nerve Fiber Layer Thickness, Brain Atrophy, and Disability in Multiple Sclerosis Patients | Abalo-Lojo, Jose Manuel; Limeres, Carmen Carollo; Gmez, Manuel Arias; Baleato-Gonzlez, Sandra; Cadarso-Surez, Carmen; Capens-Tom, Carmen; Gonzalez, Francisco | |
3 |
|
Increased Endothelin-1 Plasma Levels in Patients with Multiple Sclerosis | Haufschild, T; Shaw, SG; Kesselring, J; Flammer, J | |
4 |
|
The Effects of Auditory Distraction on Visual Cognitive Performance in Multiple Sclerosis | LaPointe, LL; Maitland, CG; Blanchard, AA; Kemker, BE; Stierwalt, JAG; Heald, GR | |
5 |
|
Stereoacuity testing discloses abnormalities in multiple sclerosis without optic neuritis. | Sobaci, Gngr; Demirkaya, Seref; Gundogan, Fatih C; Mutlu, Fatih M | |
6 |
|
Is Multiple Sclerosis Associated With a Lower Intraocular Pressure? | Norah S. Lincoff, MD, Andrea Buccilli, MD, Bianca Weinstock-Guttman, MD, Sandra Sieminski, MD, Sirin Gandhi, MD | 2017-09 |
7 |
|
Retinal Ganglion Cell Layer Volumetric Assessment by Spectral-Domain Optical Coherence Tomography in Multiple Sclerosis- Application of a High-Precision Manual Estimation Technique | Emma C. Davies, BS, Kristin M. Galetta, MS, David J. Sackel, MD, Lauren S. Talman, BA, Elliot M. Frohman, MD, PhD, Peter A. Calabresi, MD, Steven L. Galetta, MD, Laura J. Balcer, MD, MSCE | 2011-09 |
8 |
|
Retinal Ganglion Cell Layer Volumetric Assessment by Spectral-Domain Optical Coherence Tomography in Multiple Sclerosis- Application of a High-Precision Manual Estimation Technique | Davies, Emma C; Galetta, Kristin M; Sackel, David J; Talman, Lauren S; Frohman, Elliot M; Calabresi, Peter A; Steven L. Galetta, MD, NYU Langone; Balcer, Laura J | |
9 |
|
Evolving Concepts in the Pathogenesis of Multiple Sclerosis and their Therapeutic Implications | Rudick, RA | |
10 |
|
Cognitive Performance of Patients With Multiple Sclerosis and Optic Neuritis at Presentation | Ari Leshno, MD, Oded Sagiv, MD, Roy Aloni, PhD, Alon Skaat, MD, Anat Achiron, MD, Ruth Huna-Baron, MD | 2022-03 |
11 |
|
Is Neuroretinitis Associated With Multiple Sclerosis? | Miller NR, Johnson LN, Bakaeva T, Van Stavern GP, Lee AG. | 2022-03 |
12 |
|
Clinical Trials to Clinical Use: Using Vision as a Model for Multiple Sclerosis and Beyond | Laura J. Balcer, MD, Professor, Department of Neurology, NYU Langone | |
13 |
|
Macular Ganglion Cell and Inner Plexiform Layer Thickness Is More Strongly Associated With Visual Function in Multiple Sclerosis Than Bruch Membrane Opening | James Nguyen, Alissa Rothman, Natalia Gonzalez, Ama Avornu, Esther Ogbuokiri, Laura J. Balcer, Steven L. Galetta, Elliot M. Frohman, Teresa Frohman, Ciprian Crainiceanu, Peter A. Calabresi, Shiv Saidha | 2019-12 |
14 |
|
Rethinking Neuromyelitis Optica | Shelley Ann Cross | |
15 |
|
Should Optical Coherence Tomography Be Used to Manage Patients With Multiple Sclerosis? | Costello, Fiona; Van Stavern, Gregory P | |
16 |
|
Clinical outcome Measures for Research in Multiple Sclerosis | Balcer, LJ | |
17 |
|
Internuclear Ophthalmoplegia Characterizes Multiple Sclerosis Rather Than Neuromyelitis Optica Spectrum Disease | Mahmoud M. Hamza, Basheer F. Alas, Connie Huang, Justin C. Quon, Lilyana Amezcua, Michael V. Robers, Kimberly K. Gokoffski | 2022-06 |
18 |
|
Magnetic Resonance Imaging of Optic Neuritis in Patients With Neuromyelitis Optica Versus Multiple Sclerosis | Yovel, Oren S; Katz, Miriam; Leiba, Hana | |
19 |
|
Multiple Sclerosis: Eyes on the Future | Fiona E. Costello, MD, FRCPC, Jodie M. Burton, MD, MSc, FRCPC | 2018-03 |
20 |
|
Spectral-Domain Optical Coherence Tomography of Retinal Nerve Fiber Layer Thickness in NMO Patients | Lange, Alex P; Sadjadi, Reza; Zhu, Feng; Alkabie, Samir; Costello, Fiona; Traboulsee, Anthony L | |
21 |
|
Vision in Multiple Sclerosis: The Story, Structure-Function Correlations, and Models for Neuroprotection | Sakai, Reiko E; Feller Daniel J; Galetta, Kristin M; Galetta, Steven L; Balcer, Laura J | |
22 |
|
Ocular Motor Manifestations of Multiple Sclerosis | Elodie Nerrant, MD, Caroline Tilikete, MD, PhD | 2017-09 |
23 |
|
Distinguishing Optic Neuritis in Neuromyelitis Optica Spectrum Disease From Multiple Sclerosis: A Novel Magnetic Resonance Imaging Scoring System | Storoni, Mithu ; Davagnanam, Indran; Radon, Mark; Siddiqui, Ata; Plant, Gordon T | |
24 |
|
Should Spinal MRI Be Routinely Performed in Patients With Clinically Isolated Optic Neuritis? | Ethan Meltzer, MD, Elliot M. Frohman, MD, PhD, FAAN, FANA, Fiona E. Costello, MD, FRCP, Jodie M. Burton, MD, FRCP, MSc, Teresa C. Frohman, MPAS, PA-C, FANA | 2018-12 |
25 |
|
Evolution of Visual Outcomes in Clinical Trials for Multiple Sclerosis Disease-Modifying Therapies | Rachel C. Nolan, BA, Omar Akhand, BS, John-Ross Rizzo, MD, MSCI,Steven L. Galetta, MD, Laura J. Balcer, MD, MSCE | 2018-06 |